Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details) - Schedule of deferred tax assets

v3.22.1
Income Taxes (Details) - Schedule of deferred tax assets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current:    
Accrued expenses $ 144,077 $ 464,042
Stock compensation 1,800,762 869,815
Net operating loss carryforward 19,481,137 16,165,927
Research and development credit carry forward 252,536 548,983
Total deferred tax assets 21,678,512 18,048,767
Valuation allowance (21,678,512) (18,048,767)
Deferred tax asset, net of valuation allowance